Security key
03969K108
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT)
CUSIP: 03969K108
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 123,454,843
- Total 13F shares
- 59,389,299
- Share change
- +10,301,125
- Total reported value
- $1,134,920,691
- Put/Call ratio
- 8.1%
- Price per share
- $19.11
- Number of holders
- 138
- Value change
- +$194,978,652
- Number of buys
- 102
- Number of sells
- 27
Report period
Q3 2022
Institutions
138
Top holders
10
ARQT full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
6.8%
|
8,434,232
|
$179,733,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
6.2%
|
7,712,680
|
$164,357,000 | — | 30 Jun 2022 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · 10%+ Owner |
3.9%
|
4,781,646
|
$101,897,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.7%
|
4,578,153
|
$97,561,000 | — | 30 Jun 2022 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
2.4%
|
3,000,000
|
$63,930,000 | — | 30 Jun 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.6%
|
1,987,431
|
$42,352,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
1,798,663
|
$38,329,000 | — | 30 Jun 2022 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.1%
|
1,405,796
|
$29,958,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
1,396,425
|
$29,758,000 | — | 30 Jun 2022 | |
| Logos Global Management LP |
13F
|
Company |
0.81%
|
1,000,000
|
$21,310,000 | — | 30 Jun 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.75%
|
922,894
|
$19,667,000 | — | 30 Jun 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.73%
|
895,503
|
$19,083,000 | — | 30 Jun 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.64%
|
793,876
|
$16,918,000 | — | 30 Jun 2022 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.55%
|
676,678
|
$14,420,000 | — | 30 Jun 2022 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.51%
|
629,754
|
$13,420,000 | — | 30 Jun 2022 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.51%
|
623,836
|
$13,294,000 | — | 30 Jun 2022 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.46%
|
569,041
|
$12,126,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
568,666
|
$12,118,000 | — | 30 Jun 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.46%
|
564,644
|
$12,032,000 | — | 30 Jun 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.44%
|
544,188
|
$11,596,000 | — | 30 Jun 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.37%
|
453,057
|
$9,655,000 | — | 30 Jun 2022 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.35%
|
435,019
|
$9,270,000 | — | 30 Jun 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.31%
|
379,895
|
$8,095,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.29%
|
361,143
|
$7,696,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
315,058
|
$6,714,000 | — | 30 Jun 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.25%
|
312,608
|
$6,664,000 | — | 30 Jun 2022 | |
| MPM BioImpact LLC |
13F
|
Company |
0.21%
|
258,500
|
$5,509,000 | — | 30 Jun 2022 | |
| Rubric Capital Management LP |
13F
|
Company |
0.18%
|
226,346
|
$4,823,000 | — | 30 Jun 2022 | |
| AXA S.A. |
13F
|
Company |
0.18%
|
223,632
|
$4,765,598 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
217,260
|
$4,630,000 | — | 30 Jun 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.17%
|
209,175
|
$4,458,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.16%
|
192,511
|
$4,102,000 | — | 30 Jun 2022 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.15%
|
180,016
|
$3,836,000 | — | 30 Jun 2022 | |
| 1492 Capital Management LLC |
13F
|
Company |
0.14%
|
177,959
|
$3,792,000 | — | 30 Jun 2022 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.12%
|
148,874
|
$3,173,000 | — | 30 Jun 2022 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.12%
|
143,938
|
$3,067,000 | — | 30 Jun 2022 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.11%
|
136,724
|
$2,913,000 | — | 30 Jun 2022 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.09%
|
111,757
|
$2,383,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
108,169
|
$2,304,000 | — | 30 Jun 2022 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.08%
|
100,000
|
$2,131,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
96,178
|
$2,050,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
95,427
|
$2,034,000 | — | 30 Jun 2022 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.08%
|
92,653
|
$1,974,000 | — | 30 Jun 2022 | |
| Swiss National Bank |
13F
|
Company |
0.06%
|
71,200
|
$1,517,000 | — | 30 Jun 2022 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.05%
|
66,635
|
$1,420,000 | — | 30 Jun 2022 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.05%
|
66,495
|
$1,417,000 | — | 30 Jun 2022 | |
| NORGES BANK |
13F
|
Company |
0.05%
|
61,116
|
$1,302,382 | — | 30 Jun 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.04%
|
49,047
|
$1,045,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
45,818
|
$976,000 | — | 30 Jun 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.03%
|
42,377
|
$903,000 | — | 30 Jun 2022 |
Institutional Holders of Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT) as of Q3 2022
As of 30 Sep 2022,
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,389,299 shares.
The largest 10 holders included
FMR LLC, Frazier Life Sciences Management, L.P., BlackRock Inc., Point72 Asset Management, L.P., Bain Capital Life Sciences Investors, LLC, ORBIMED ADVISORS LLC, STATE STREET CORP, VANGUARD GROUP INC, PICTET ASSET MANAGEMENT SA, and Logos Global Management LP.
This page lists
138
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
112
Q3 2022 holders
138
Holder diff
26
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.